Multiple Sclerosis :: Update on Tysabri in multiple sclerosis patients

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that new data from the TOUCH Prescribing Program? and TYGRIS safety study confirm the safety profile from previous clinical studies of TYSABRI? (natalizumab). Also presented at the 59th annual meeting of the American Academy of Neurology in Boston, MA were extension study data that showed that TYSABRI has a sustained treatment effect on clinical relapses and the risk of disability progression in multiple sclerosis (MS) patients treated for up to three years.

Parkinson’s Disease :: Link between Parkinson’s disease and Narcolepsy

Parkinson’s disease is well-known for its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking. Less well known is that Parkinson’s shares other symptoms with narcolepsy, a sleep disorder characterized by sudden and uncontrollable episodes of deep sleep, severe fatigue and general sleep disorder.

Asthma :: Asthma on decline in Australia

A report released on World Asthma Day, by the Australian Institute of Health and Welfare says asthma, especially among children and young adults, is on the decline but notes that socioeconomic disparities are widening.

Lung Cancer :: Statins shown to prevent lung cancer

New research shows that statins appear to protect against the development of lung cancer. The large population study, conducted by researchers from Louisiana State University and the Overton Brooks VA Medical Center, consisted of data collected over a 6-year period from the VA Health Care System.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack